Good to stronger half half Peter. and quarter. cost afternoon first a gross thank of lower for comparison half a first better much in our in improvement very income. first completed We joining us margin, good the strong revenue Thanks, XXXX today. much and of delivered in the and continued you XXXX, net second We've
half. the is second and Our the of strategy very first profitable growth momentum a expect of delivering we build to working strong on strong half
business the Then update. will year-to-date I During cover our half. execution provide an take we performance, and questions. our both will call, second second the outlook and your of provide a will Kathy for strategic quarter progress our on initiatives financial
X% no or quarter We of E you XXXX revenue business by Vitamin in supplied now delivered start XXXX DSM, sales and the XX% portfolio. that Let over growth performance. of when over product Amyris adjust are the produced our first longer the me and with growth the second supplied quarter for
the than our beauty markets, strength better are of business and the the half we testament health demand strong sold experiencing focusing adjusting and core great strategy This the Vitamin is of portfolio. contract half our our portfolio first E improvement product within model a of XXXX the XX% example DSM. great and of XXXX, first like-for-like product to is our a of Our on and revenue of when to simplification
margins EBITDA gross strong top-line performance, the adjusted XXXX. also improved to and much are addition over our In
is our million Our adjusted better. $X.X better first XXXX $X.X EBITDA versus half second and is XXXX the of million quarter in XXXX,
of the from significantly improved XXXX. also has profit gross first Our half
second Clean at ingredient XX% of and the this business, the quarter the non-GAAP is first-half revenue half also our level. of consistent also sweetener second collaboration year, ingredients and and First in the the on gross of with collaborations collaborations. new half our XXXX. XXXX, of at of our XX% second are the business In the gross producing expected margin. of of back This had of are gross we performance in predominantly year. Beauty XX% of in most single our half half our are with of XXXX, value-share/royalty we We phasing the model first margin margin we Most and delivered all non-GAAP the annual agreements sell batches consistent shipments, the last our new payments
final year the contract of or either phase. is this contracted expected All revenue in the for
well Our continuing we expected. business than Clean and is Beauty our do to royalty/value-share is growing faster
are track consumer planned initially a higher This ingredient XX% of for renewable plan we in unprecedented XXXX all volume product our in than the shift for for our on businesses. and sustainably aggregate We of are sourced. to strong XXXX products is natural the that us indicator high-performing our be to
we skincare information the around clean brand America, market. North growing fastest the based become has beauty brand in Biossance have the Our on
always in are of the all to million licensing have negative have contract Our for in in has year, complexity are quarter the in impact because full to the arrangements half This that as two collaboration we The would other major had of economics. on expect resulted of in of deals And deferral agreements, long-term individual the strategic are but now We've will be China into we it move in also the fall half predictable decided has we the in second implications expect quarter. These been second potential the stage collaborations to these occur sequence quarter at of strategic royalty important the second realize on for continues the revenue deals a this. the additional China. now $XX an second that that of revenue signing quarter. to and collaboration not and choppy plan. and our quarter to us collaborations for would said reason We this this the the that to with year.
China. the with in pleased made very we've are progress We
recognized pharma a have scaling We in leader developing, very for products value exciting high the pipeline. intermediates and now ingredients are and industries, and manufacturing and the nutritional as generic
begin to complete compared we with the for and for our to expectations half we You'll In delivered ingredients track on the while third business than first of our plan the full some attraction we sustainable natural Biossance are a planned of XXXX on set demand investors best-in-class summary, zero-calorie brand for our first year quarter. XXXX, sweetener. the we deliver of for of this with with doing performing very half as strong and better and strong our product experience
on basis. volume year an underlying year We are doubling product the on
to the now natural doing natural we confirmed product the we're market. on that sweetener leading on solution companies of execution doing purest strategic zero-calorie best three the of natural agenda. sweetener me how is transition On have the with sweetener world's We've Let program performing great. our sweetener, our and
continuing about million our four potential have to executing, learn this margin in the three with $XX next in revenue are progress. $XXX gross of our most called and customers. of contract the lowest cost This of these for end for sweetener high we over our while years, and any over the now are report phase Over products and markets. to by the supply period available have of leaders their each performance non-GAAP and four been natural that very XXXX respective to represents supply product, aggregate We've million purity quietly customers excited
the with the the excellent making healthy consumer in for a and are at time for is taste, game This deliver partners. that huge economics difference of sustainability right a our great a the is to cost an is We market. product This sweetener experience tastes great changer. and
Our a value have the cost goal is leading the is natural same sweetener to the sugar of equivalency. world's from sweetness that
continue more of this And be the in reduction goal achieve at objective That market. to sugar with have natural our work sugar. enables long-term cost do us to see to the as to our to that sweetener. We target we win the
performance outstanding the Biossance half. has Our been in first
compares indicators in retail on for consumers to are in and XXXX. retail Many million great products proof now a about great and segment engage consumer our million best-in-class of XXXX. of for brand build our of powerful a our this $X the sales are We exceed to performance to performance key of and track This way. $XX sales a in ability
is their numbers reports now growth, year-on-year we XXX% We about that brand and growing this fastest of Beauty delivering the believe publically. are in Clean company any
expect We products, the the growth to of continue and channels this next level for this support we and level few have to of performance. consumers years,
expect brand, baby on the and based to We we our multiples, achieve for category, years. our current expected business for for over launches care are Clean of $X men. this our Beauty includes products This next type-evaluation to on three creating the hair billion way
our clean meet these have Compromise our products in of and winning each promise. categories product on that We deliver standard No
a oil spread but wrong Babies to for the wrong healthy choose. crude ability world clean the and on skin. for for This wrong don't finally to We doesn't is our are skins, baby their planet, a excited make place have really have that deserve for the to babies.
our to performance. our pleased & of hear are for Johnson We safety, they we standards and of that Johnson level level adoption is for hope formulate
love than purchases promise best are healthy. and from the and heart is use and and consumers Beauty. and who brand This our No of customers, performing Our only lead our purchasing our products. more the We year Clean loyalists, only are Compromise Biossance. three times from sustainable Biossance a what to of our desire are in Around is XX% from love at XX% repeat ingredients
we've a of the skin our and and three six Our the categories inside example Sephora performance of Brazil, entry in market, brands of several our their into are top Brazil. this Within within in in brand. one now products Brazil is of become the five products weeks top care entering of great
Another performance year. been products a sales over is looking of comp way at SKUs Biossance selling by to our that individual of for view have
deliver selling a four these XX% Our comps target on well growth, with in retail about for this been have each of each year $X over that sales products to million is year. over over
with as million of end monthly the We monthly year of over expect our $X rate. sales sales the
business gross to in this Biossance with the to continue brand our are and believe for profitable grow expect starting offers. strong We this only we consumer Biossance deliver year much and We be very full performance have with to and more point and XXXX. at margin
Let me now with outlook. our end
$XXX achieve target million deliver stated to of and $XXX full-year our prior of range to expect a We to million. around revenue $XX positive million, EBITDA with
Biossance, two license the payments, drivers major that continued key half of revenue second in produced for major of shipments are shipped year. half Our second collaborations, batch strong of the the are and ingredient growth our key three that
and half business no activity, have is control second base In Aprinnova over second and greatly of benefitting performance, DSM our half $XX Nenter. have Nenter million we And we second a built from half confident for market. the that's profit $XXX of deliver responsible The million is Vitamin care now commercial within the $XXX $XXX This value over represent gross half excess revenue natural of of we a this joint into in been royalty. in of expected that have control about by and these first business that $XXX revenue. of our plan and is feel area to and very activities the sales and sold of venture, expect the for on is million that's supply. our $XX price In exceeding market for no the second million between areas and sweetener this very market million receiver and a our we royalty performance of business We product and E million based to price of $XXX are royalties the the aggregate, expected that These Our share great our volatile the skin purely only volume our the business for we Biossance. control. half. between million revenue second
is We at consumer our will for strong that market price demand This deliver care that very our but guarantee key been of very performance. products is have growth to always sweetener business. The sustainable great natural there and effective skin are driving we drivers predicting get no date, right. this
oil large ingredients, sustainable $XX have crude wanting at advantage to brands above is that the is vitamins global also the when barrel. technology lower significantly to a addition make In we cost
leading the lowest Biossance our have the we sweetener; Beauty our within and We Clean the joint businesses all market cost the our natural to technology Aprinnova are These portfolio, are businesses three portfolio. and off vitamin now including we experiencing and in venture, where have beyond growth are our expectations. races: have
and and Our gross best our margin our quality of strategy of the earnings is product indicator power portfolio. the
I and in non-GAAP are margin. we'll XX% north gross gross year-to-date, We well XX% at believe, of end margin the year non-GAAP
throughout fuels unit to markets. for participate gross of by sector are I each in differently, sustainable a of of renewable a less kilo the what produce, kilo $XX of into best product margin resource commodity performance we We in for said products gross margin best and do enough world. in for in $XX becoming are a kilo for for natural product revenue industry sustainability and potential great kilo that kilo bet and company to that kilo to - the biotechnology of for chemicals this against is those revenue of deliver we disruptive every every investors every $X.XX wanting $XX material of product or than believe is Compare produce. mainstream our than sold making generating this the consumers $X notice. and can get far, clean, any This and of is, revenue for less an currently a
a me let quarter. the Kathy to financial turn Kathy? second Now of for review detailed
